查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995240

乳房切片器材市場：2026年至2032年全球市場預測（依產品類型、手術類型、技術、類別、應用、最終用戶和分銷管道分類）

Breast Biopsy Device Market by Product, Procedure Type, Technique, Category, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，乳房切片設備市場價值將達到 24.2 億美元，到 2026 年將成長至 25.7 億美元，到 2032 年將達到 38.1 億美元，複合年成長率為 6.70%。

主要市場統計數據
基準年 2025 24.2億美元
預計年份：2026年 25.7億美元
預測年份 2032 38.1億美元
複合年成長率 (%) 6.70%

過去十年，影像技術和流程的進步從根本上改變了乳房病變的診斷方法。臨床醫生現在透過將高解析度成像與微創切片檢查相結合，最佳化了診斷準確性，從而減輕了患者的不適感，並簡化了臨床流程。早期檢測策略不再局限於傳統的乳房X光攝影；斷層合成、超音波和磁振造影（MRI）引導技術的整合，開啟了標靶治療的新時代，並提高了病變的識別率和組織特徵分析能力。

同時，醫療設備製造商正在增加各種切片穿刺針、引導系統以及相關產品，例如立體定位導線和手術台，以支援複雜的手術操作。從純手動設備向自動化系統的轉變，凸顯了臨床環境中工作流程精簡和可重複化的整體趨勢。隨著對病患安全的日益重視，產品設計現在更加重視人體工學、即時回饋以及與數位影像網路的兼容性。

本執行摘要概述了影響乳房切片設備行業的關鍵趨勢。它概述了變革性的技術變革，評估了監管和貿易趨勢的影響，檢驗了特定細分領域的洞察，分析了區域和競爭格局，並提出了策略建議。其目的是幫助決策者深入了解產業現狀，並專注於創新和投資能夠帶來最大臨床和商業性回報的可行領域。

乳房切片技術的重大模式轉移以及臨床實踐的演變，重新定義了患者的治療結果、效率和準確性。

臨床醫生和產業領袖正見證著乳房切片手術計畫和實施方式的模式轉移。超音波和斷層合成引導的廣泛應用減少了對立體定位平台的依賴，從而能夠更精準地定位觸診不到的病灶，並提高診斷準確性。同時，磁振造影（MRI）引導技術對於高風險患者而言已變得至關重要，它能夠提供無與倫比的軟組織對比度，並可靠地觸及深部和後部病灶。

評估近期美國關稅對切片檢查設備製造商供應鏈成本結構和競爭力的廣泛影響。

美國當局將於2025年對醫療設備零件徵收新關稅，這給切片檢查設備製造商和醫療服務提供者帶來了新的挑戰。依賴特種合金和微加工導向零件的供應商正面臨不斷上漲的投入成本壓力，被迫重新評估其全球籌資策略。為此，一些設備製造商正在加速向國內生產轉型，或在貿易環境更有利的地區尋找替代零件供應商。

對產品類型、流程類型、技術、類別、應用和最終用戶群進行詳細和全面的分析，以獲得策略見解。

透過按類型評估產品，我們可以更深入地了解設備性能和用戶需求的細微差別。這包括專為生物標記分析客製化的檢測試劑盒、針對組織取樣最佳化的各種切片穿刺針、便於患者定位的可客製化治療床、整合多種成像模式的先進導航系統以及用於精確標記病灶的精密定位導絲。每個產品類型都對應診斷工作流程的不同階段，凸顯了整個治療生態系統相容性和互通性的重要性。

區域展望：美洲、歐洲、中東和非洲以及亞太地區的獨特需求因素、機會和挑戰

美洲地區的趨勢反映了其完善的醫療基礎設施，完善的報銷機制和大規模篩檢計畫推動了影像導引切片檢查解決方案的快速普及。在美國，高手術量和醫生對微創手術的強烈偏好引領了自動化真空輔助系統和先進導引系統的應用。同時，拉丁美洲市場雖然對價格較為敏感，但隨著即時檢測的推進，對攜帶式超音波引導設備的需求也不斷成長。

領先設備製造商的策略概況和創新藍圖，協助其在乳房切片領域獲得競爭優勢

乳房切片設備領域的主要企業正利用其在研發方面的策略性投資，推出新一代採樣工具和更完善的數位化工作流程。擁有全面診斷產品組合的成熟企業集團正在將其切片檢查平台與雲端影像管理系統整合，以實現無縫資料交換和遠距離診斷支援。與這些功能豐富的產品線形成對比的是，還有一些設備創新者專注於特定應用領域，例如相容MRI的切片穿刺針和快速現場評估試劑盒。

針對製造商、醫療保健提供者和投資者，提出具體的策略建議，以抓住乳房切片。

為鞏固市場地位，製造商應優先開發整合影像引導、自動化和數位化報告功能的平台。透過讓產品藍圖與臨床醫生的工作流程和電子健康記錄系統保持一致，企業可​​以降低產品推廣門檻，並在手術效率和診斷準確性方面展現顯著價值。同時，增加對培訓計畫和模擬教學的投入，將進一步提升使用者技能，並有助於建立更牢固的客戶關係。

採用綜合性的多元方法研究方法，結合一手質性訪談、二手資訊和嚴格的檢驗過程。

本研究採用多方面方法，結合了對乳房攝影專家、介入性放射科醫師和外科腫瘤醫師的深入定性訪談。透過全面審查這些主要發現以及同行評審期刊、監管文件和專業學會指南，確保了臨床和科學的嚴謹性。研究還運用了來自多個資訊來源的資料點進行三角驗證，以檢驗手術流程趨勢、設備採用率和區域部署模式。

整合關鍵洞察，突顯創新採納、市場變化、監管趨勢以及相關人員。

在先進成像、自動化採樣和數位分析工具融合的推動下，乳房切片設備市場格局正以驚人的速度演變。微創技術的普及減輕了患者的負擔，同時也提高了診斷的可靠性。同時，全球貿易趨勢和關稅結構的變化迫使相關人員重新評估其供應鏈策略和區域夥伴關係。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：乳房切片設備市場：依產品分類

  • 檢測試劑盒
  • 切片穿刺針
  • 切片檢查
  • 導航系統
  • 定位線

第9章：依手術類型分類的乳房切片設備市場

  • 核心針穿刺切片
  • 細針穿刺切片檢查
  • 穿刺輔助切片檢查

第10章：乳房切片設備市場：依技術分類

  • 磁共振引導
  • 立體定位
  • 斷層合成引導系統
  • 超音波引導

第11章：乳房切片設備市場：按類別分類

  • 自動切片檢查裝置
  • 手動切片檢查裝置

第12章乳房切片設備市場：依應用領域分類

  • 良性病變的診斷
  • 惡性病變的診斷

第13章乳房切片設備市場：依最終用戶分類

  • 門診手術中心
  • 診斷影像中心
  • 醫院

第14章乳房切片設備市場：依分銷管道分類

  • 線下銷售
  • 線上銷售

第15章：乳房切片設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章乳房切片設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章乳房切片設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國乳房切片設備市場

第19章：中國乳房切片設備市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Health Care
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Danaher Corporation
  • FUJIFILM Corporation
  • General Electric Company
  • Halma plc
  • Hologic, Inc
  • INRAD Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • PAJUNK GmbH
  • Planmeca Oy
  • Point Blank Medical
  • Siemens AG
  • SNVL Varay Laborix
  • STERYLAB Srl
  • Suretech Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vector Medical, Inc.
  • Zamar Care
Product Code: MRR-807A20B5CD96

The Breast Biopsy Device Market was valued at USD 2.42 billion in 2025 and is projected to grow to USD 2.57 billion in 2026, with a CAGR of 6.70%, reaching USD 3.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.57 billion
Forecast Year [2032] USD 3.81 billion
CAGR (%) 6.70%

Over the past decade, advancements in imaging modalities and procedural techniques have fundamentally altered the approach to diagnosing breast lesions. Clinicians now combine high-resolution visualization with minimally invasive sampling to optimize diagnostic precision, reducing patient discomfort and streamlining care pathways. Early detection strategies are no longer confined to standard mammography; the integration of tomosynthesis, ultrasound, and magnetic resonance guidance has ushered in a new era of targeted interventions that improve lesion localization and tissue characterization.

In parallel, device manufacturers have expanded their portfolios to include a diverse array of biopsy needles, guidance systems, and ancillary products such as localization wires and tables that support complex procedures. The transition from purely manual devices to automated systems underscores a broader trend toward workflow efficiency and reproducibility in clinical settings. With an increased focus on patient safety, product designs now prioritize ergonomics, real-time feedback, and compatibility with digital imaging networks.

This executive summary synthesizes the critical trends shaping the breast biopsy device domain. It outlines transformative technological shifts, assesses the impact of regulatory and trade dynamics, examines segment-specific insights, evaluates regional and competitive landscapes, and presents strategic recommendations. The goal is to equip decision-makers with a nuanced understanding of the industry's trajectory and to highlight actionable areas where innovation and investment can yield the greatest clinical and commercial returns.

Key Paradigm Shifts in Breast Biopsy Technologies and Evolving Clinical Practices Redefining Patient Outcomes Efficiency and Precision

Clinicians and industry leaders alike are witnessing a paradigm shift in how breast biopsy procedures are planned and executed. The widespread adoption of ultrasonography and tomosynthesis guidance has reduced reliance on stereotactic platforms, enabling more precise targeting of non-palpable lesions and augmenting diagnostic yield. Concurrently, magnetic resonance guided techniques have become indispensable for high-risk patients, offering unparalleled soft-tissue contrast and the ability to access deep or posterior lesions with confidence.

Beyond imaging, the transition from core needle and fine needle aspiration to vacuum assisted biopsy systems reflects an emphasis on obtaining larger tissue volumes while minimizing sampling error. This shift has been accompanied by the development of next-generation biopsy needles that leverage advanced tip geometries and hydrophilic coatings to reduce insertion force and improve specimen integrity. These enhancements have translated into fewer needle passes, shorter procedure times, and a lower incidence of patient discomfort.

Artificial intelligence and artificial vision technologies are now being integrated into guidance platforms to assist with lesion segmentation and needle path planning. Such digital augmentation not only accelerates decision-making in the procedure room but also supports telemedicine applications, enabling remote expert consultation in real time. As a result, service providers are redefining care models to deliver faster turnarounds and more personalized diagnostic experiences, heralding a new chapter in precision breast health management.

Evaluating the Broad Effects of Recent United States Tariffs on the Supply Chain Cost Structures and Competitive Dynamics of Biopsy Device Manufacturers

The imposition of new tariffs on imported medical device components by United States authorities in 2025 has introduced a fresh layer of complexity for biopsy device manufacturers and healthcare providers. Suppliers reliant on specialized alloys and microfabricated guidance parts have experienced upward pressure on input costs, prompting a reevaluation of global sourcing strategies. In response, some device makers have accelerated their shift toward domestic production or have sought alternative component suppliers in trade-friendly regions.

Pricing adjustments have rippled through procurement budgets at ambulatory surgery centers, diagnostic imaging centers, and hospital systems, leading to more vigorous price negotiations and, in certain instances, the delayed adoption of premium biopsy tables and guidance systems. Simultaneously, manufacturers with in-house vertical integration have demonstrated greater resilience, securing operational continuity while maintaining tighter control over cost structures. These firms have been better positioned to weather the tariff-induced disruptions and to preserve customer relationships through value-added service agreements.

Looking ahead, the threat of additional trade measures has underscored the importance of cross-border regulatory alignment and the cultivation of dual-sourcing networks. Strategic partnerships between device innovators and regional contract manufacturing organizations have gained momentum as a means to safeguard supply chain robustness. Ultimately, the 2025 tariff landscape has reinforced the critical interplay between geopolitical factors and clinical technology deployment, shaping the competitive dynamics of the biopsy device domain.

In-Depth Comprehensive Analysis of Product Procedure Type Technique Category Application and End User Segments for Targeted Strategic Insights

A nuanced understanding of device performance and user requirements emerges when assessments are segmented by product type, encompassing offerings such as assay kits tailored for biomarker analysis, a range of biopsy needles optimized for tissue capture, customizable procedure tables that facilitate patient positioning, advanced guidance systems that integrate imaging modalities, and precision localization wires designed for accurate lesion marking. Each product category addresses a distinct phase of the diagnostic workflow, underscoring the importance of compatibility and interoperability across the procedural ecosystem.

Procedural segmentation reveals that core needle biopsy remains a mainstay for sampling both palpable and non-palpable masses, while fine needle aspiration continues to serve in cytology-driven contexts where minimal tissue disruption is paramount. Vacuum assisted biopsy has gained traction among clinicians seeking larger specimens and lower repeat rates, with automated devices offering consistent sampling profiles that reduce user dependency.

Technique-based differentiation highlights the growing prevalence of MRI guided interventions in high-complexity cases, juxtaposed with the ubiquity of ultrasound guided methods in routine screenings and diagnostic follow-ups. Tomosynthesis guided biopsies have emerged as a hybrid approach, delivering three-dimensional lesion visualization with lower radiation exposure than traditional stereotactic guidance.

From a device category perspective, automated systems are increasingly favored for their reproducibility and workflow integration, while manual devices retain their appeal in resource-constrained settings and mobile screening units. Applications span the spectrum from benign lesion diagnosis, where rapid turnover and cost-effectiveness are prioritized, to malignant lesion diagnosis, which demands the highest levels of sampling accuracy and tissue integrity. End user considerations further differentiate demand across ambulatory surgery centers known for efficiency, diagnostic imaging centers valued for specialized expertise, and hospitals that accommodate complex case mixes. Finally, distribution channels bifurcate into offline sales, driven by established procurement processes, and online sales, which have gained momentum through digital catalogues and e-commerce portals.

Regional Outlook Revealing Unique Demand Drivers Opportunities and Challenges Across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics in the Americas reflect a consolidated healthcare infrastructure, where reimbursement frameworks and large-scale screening programs have catalyzed the rapid uptake of image-guided biopsy solutions. The United States leads in the adoption of automated vacuum assisted and advanced guidance systems, driven by high procedure volumes and strong physician preferences for minimally invasive approaches. Meanwhile, Latin American markets, though more price-sensitive, are showing growing demand for portable ultrasound guided devices that align with point-of-care testing initiatives.

In Europe, Middle East and Africa, heterogeneity in healthcare funding and regulatory pathways influences the diffusion of new technologies. Western Europe's mature reimbursement environment supports the integration of tomosynthesis and MRI guided platforms, whereas parts of the Middle East are investing heavily in cutting-edge facilities to serve medical tourism sectors. African regions with limited infrastructure tend to adopt manual and cost-effective biopsy needles, although pilot programs in tertiary centers are testing more sophisticated guidance equipment.

The Asia Pacific region is characterized by dynamic growth, propelled by rising breast cancer awareness and expanding public healthcare expenditure. Emerging economies are prioritizing the deployment of ultrasound guided systems in community hospitals, while advanced markets in Japan and Australia emphasize precision imaging and the standardization of biopsy protocols. Local manufacturing initiatives and government-sponsored screening drives are shaping regional procurement strategies, underscoring the importance of scalable solutions that align with diverse clinical and economic environments.

Strategic Profiles and Innovation Roadmaps of Leading Device Manufacturers Driving Competitive Edge in the Breast Biopsy Space

Leading participants in the breast biopsy device space are leveraging strategic investments in research and development to introduce next-generation sampling tools and digital workflow enhancements. Established conglomerates with comprehensive diagnostic portfolios are integrating biopsy platforms with cloud-enabled image management systems, enabling seamless data exchange and remote diagnostic support. These feature-rich offerings are contrasted by specialized device innovators focusing on niche applications such as MRI compatible biopsy needles and rapid on-site evaluation kits.

Mergers and partnerships have become instrumental in expanding technological capabilities, with several key players forming alliances with software providers to embed artificial intelligence modules into guidance consoles. These collaborations emphasize real-time lesion detection and adaptive needle trajectory optimization, setting the stage for reduced procedural variability and improved clinical confidence. At the same time, smaller regional manufacturers are targeting cost-effective device designs tailored to emerging economies, fostering competitive pricing dynamics and expanding access to basic image-guided biopsy services.

Intellectual property portfolios further delineate competitive positioning, as patents covering proprietary needle tip geometries and automation algorithms block new entrants from replicating critical design features. Service contracts and recurring consumables also serve as anchors for customer loyalty, creating recurring revenue streams that support continuous innovation. Collectively, these strategic moves are reshaping the competitive landscape, with innovation velocity and integrated digital solutions emerging as the primary differentiators among industry leaders.

Targeted Strategic Recommendations for Manufacturers Healthcare Providers and Investors to Seize Opportunities and Mitigate Risks in the Breast Biopsy Sector

Manufacturers aiming to solidify their presence should prioritize the development of integrated platforms that combine imaging guidance, automation, and digital reporting functionalities. By aligning product roadmaps with clinician workflows and electronic medical record systems, companies can reduce adoption barriers and demonstrate clear value in procedure efficiency and diagnostic accuracy. Parallel investments in training programs and simulation-based education will further support user proficiency and foster stronger customer relationships.

Healthcare providers are encouraged to evaluate device portfolios holistically, considering not only upfront acquisition costs but also long-term service agreements, consumable consumptions, and potential for integration with existing imaging networks. Engaging with multiple suppliers to pilot emerging technologies can reveal best-fit solutions for specific patient populations and facility requirements. Embracing flexible procurement models, such as pay-per-use or outcome-based contracts, may also mitigate budgetary pressures and accelerate technology adoption.

Investors and industry partners should seek opportunities in regions where screening initiatives are scaling rapidly and regulatory environments are adapting more quickly to digital health solutions. Strategic collaborations with local contract manufacturers and clinical centers can de-risk market entry and facilitate the development of tailored offerings. By focusing on segments with high unmet clinical needs, such as MRI guided biopsy systems for dense breast tissue, stakeholders can position themselves at the forefront of emerging growth corridors.

Comprehensive Multimethod Research Approach Integrating Primary Qualitative Interviews Secondary Data Sources and Rigorous Triangulation Processes

This research employed a multimethod approach combining in-depth qualitative interviews with leading breast imaging specialists, interventional radiologists, and surgical oncologists. These primary insights were complemented by a comprehensive review of peer-reviewed journals, regulatory filings, and professional society guidelines to ensure clinical and scientific rigor. Data points were triangulated across multiple sources to validate procedural trends, device adoption rates, and regional deployment patterns.

Secondary research included an analysis of regulatory databases for device approvals and import-export records to quantify the influence of trade policies. Intellectual property landscapes were mapped using patent registries, while corporate financial statements and investor presentations provided context on strategic priorities and R&D investments. Market intelligence from healthcare conferences and expert panels informed the identification of emerging technologies and ecosystem partnerships.

Throughout the research process, all findings were subjected to peer review by an external advisory board comprising clinicians and industry consultants. This iterative validation step enhanced the reliability of conclusions and ensured that the final report delivers actionable insights grounded in the latest clinical practices and commercial realities.

Synthesis of Critical Findings Underscoring Innovation Adoption Market Shifts Regulatory Developments and Strategic Imperatives for Stakeholders

The breast biopsy device landscape is evolving at a remarkable pace, driven by the convergence of advanced imaging, automated sampling, and digital analysis tools. The shift toward minimally invasive procedures is reducing patient burden while elevating diagnostic confidence. Simultaneously, global trade dynamics and tariff structures are compelling stakeholders to rethink supply chain strategies and regional partnerships.

Segment-driven insights reveal that product innovation must be tailored to distinct clinical workflows, from rapid cytology in aspiration procedures to high-throughput vacuum assisted systems. Regional patterns underscore the necessity of adaptable solutions that address both resource-rich and resource-constrained environments, highlighting the opportunity for scalable device architectures.

Competitive intensity is shaped by a blend of deep-pocketed multinationals integrating AI capabilities and agile niche players customizing cost-effective offerings for localized markets. Future success will hinge on the ability to harmonize technological advancements with streamlined service models, supported by robust training and digital integration. These strategic imperatives will guide industry participants as they navigate an increasingly complex and opportunity-rich clinical milieu.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Biopsy Device Market, by Product

  • 8.1. Assay Kits
  • 8.2. Biopsy Needles
  • 8.3. Biopsy Tables
  • 8.4. Guidance Systems
  • 8.5. Localization Wires

9. Breast Biopsy Device Market, by Procedure Type

  • 9.1. Core Needle Biopsy
  • 9.2. Fine Needle Aspiration
  • 9.3. Vacuum Assisted Biopsy

10. Breast Biopsy Device Market, by Technique

  • 10.1. MRI Guided
  • 10.2. Stereotactic
  • 10.3. Tomosynthesis Guided
  • 10.4. Ultrasound Guided

11. Breast Biopsy Device Market, by Category

  • 11.1. Automated Biopsy Devices
  • 11.2. Manual Biopsy Devices

12. Breast Biopsy Device Market, by Application

  • 12.1. Benign Lesion Diagnosis
  • 12.2. Malignant Lesion Diagnosis

13. Breast Biopsy Device Market, by End User

  • 13.1. Ambulatory Surgery Centers
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals

14. Breast Biopsy Device Market, by Distribution Channel

  • 14.1. Offline Sales
  • 14.2. Online Sales

15. Breast Biopsy Device Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Breast Biopsy Device Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Breast Biopsy Device Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Breast Biopsy Device Market

19. China Breast Biopsy Device Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advin Health Care
  • 20.6. Argon Medical Devices, Inc.
  • 20.7. Becton, Dickinson and Company
  • 20.8. Cook Group Incorporated
  • 20.9. Danaher Corporation
  • 20.10. FUJIFILM Corporation
  • 20.11. General Electric Company
  • 20.12. Halma plc
  • 20.13. Hologic, Inc
  • 20.14. INRAD Inc.
  • 20.15. Medline Industries, LP
  • 20.16. Medtronic PLC
  • 20.17. Merit Medical Systems, Inc.
  • 20.18. Ningbo Xinwell Medical Technology Co., LTD.
  • 20.19. PAJUNK GmbH
  • 20.20. Planmeca Oy
  • 20.21. Point Blank Medical
  • 20.22. Siemens AG
  • 20.23. SNVL Varay Laborix
  • 20.24. STERYLAB S.r.l.
  • 20.25. Suretech Medical Inc.
  • 20.26. Thermo Fisher Scientific Inc.
  • 20.27. Trivitron Healthcare
  • 20.28. Vector Medical, Inc.
  • 20.29. Zamar Care

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)